Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer-Reference-Cited by-同舟云学术

Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer

Published:2017-10-15 Issue:4 Volume:49 Page:906-914
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Lee Min-Young,Ku Bo Mi,Kim Hae Su,Lee Ji Yun,Lim Sung Hee,Sun Jong-Mu,Lee Se-Hoon,Park Keunchil,Oh Young Lyun,Hong Mineui,Jeong Han-Sin,Son Young-Ik,Baek Chung-Hwan,Ahn Myung-Ju

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-2016-424.pdf

Reference29 articles.

1. Increasing incidence of thyroid cancer: controversies explored

2. A Closer Look at Papillary Thyroid Carcinoma

3. High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid Carcinoma

4. Molecular pathogenesis and mechanisms of thyroid cancer

5. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FHL1: A novel diagnostic marker for papillary thyroid carcinoma;Pathology International;2024-08-09

2. Aggressive value of preoperative multi-genic assay and implications for initial surgical management in papillary thyroid cancer;2024-06-17

3. BRAF V600E mutation co-existing with oncogenic mutations is associated with aggressive clinicopathologic features and poor prognosis in papillary thyroid carcinoma;Asian Journal of Surgery;2024-01

4. A new paradigm for epidermal growth factor receptor expression exists in PTC and NIFTP regulated by microRNAs;Frontiers in Oncology;2023-04-11

5. Essential news for clinical practice—thyroid cancer;memo - Magazine of European Medical Oncology;2023-01-10